4.7 Article

Brain parenchymal and leptomeningeal metastasis in non-small cell lung cancer

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Cancer statistics, 2022

Rebecca L. Siegel et al.

Summary: Each year, the American Cancer Society compiles data on cancer occurrence and outcomes in the United States. The latest data shows that breast and prostate cancer progress has stagnated, while lung cancer has shown improvements in survival rates. Lung cancer incidence for advanced disease has declined while localized-stage rates have increased, resulting in higher survival rates. Mortality patterns align with incidence trends, with lung cancer deaths declining rapidly, breast cancer deaths slowing, and prostate cancer deaths stabilizing.

CA-A CANCER JOURNAL FOR CLINICIANS (2022)

Article Oncology

Systematic Immunological Level Determined the Prognosis of Leptomeningeal Metastasis in Lung Cancer

Ye Hong et al.

Summary: This study aimed to explore the relationship between the systematic immunological level and prognosis of lung cancer patients with leptomeningeal metastases (LM), and to establish a prognostic model for predicting patient survival. The results showed that the systematic immunological level was an independent prognostic factor for these patients.

CANCER MANAGEMENT AND RESEARCH (2022)

Article Oncology

Identification of a high-risk group for brain metastases in non-small cell lung cancer patients

Bernardo Cacho-Diaz et al.

Summary: The study successfully identified a high-risk group of brain metastases in NSCLC patients by generating a multivariable model incorporating factors such as age, carcinoembryonic antigen levels, and mutation status. Early interventions based on this model could potentially lead to improved prognosis for these patients.

JOURNAL OF NEURO-ONCOLOGY (2021)

Article Oncology

The construction and validation of the model for predicting the incidence and prognosis of brain metastasis in lung cancer patients

Chunjian Zuo et al.

Summary: This study aimed to develop models for predicting the development and prognosis of brain metastasis (BM) in lung cancer (LC) patients using a large cohort. Risk factors for developing BM and prognosis were identified, and nomograms were constructed based on these factors, showing good performance in predicting BM development and prognosis.

TRANSLATIONAL CANCER RESEARCH (2021)

Article Medicine, General & Internal

Brain metastases

Achal Singh Achrol et al.

NATURE REVIEWS DISEASE PRIMERS (2019)

Review Oncology

Potential Molecular Signatures Predictive of Lung Cancer Brain Metastasis

Rute M. S. M. Pedrosa et al.

FRONTIERS IN ONCOLOGY (2018)

Review Oncology

The Evolving Landscape of Brain Metastasis

Manuel Valiente et al.

TRENDS IN CANCER (2018)

Article Oncology

A Nomogram to Predict Brain Metastases of Resected Non-Small Cell Lung Cancer Patients

Fanrong Zhang et al.

ANNALS OF SURGICAL ONCOLOGY (2016)

Article Clinical Neurology

Leptomeningeal metastases in the MRI era

J. L. Clarke et al.

NEUROLOGY (2010)